Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

A stochastic model of myeloid cell lineages in hematopoiesis and pathway mutations in acute myeloid leukemia.

Jäkel F, Worm O, Lange S, Mertelsmann R.

PLoS One. 2018 Oct 1;13(10):e0204393. doi: 10.1371/journal.pone.0204393. eCollection 2018.

2.

Development of image analysis software for quantification of viable cells in microchips.

Georg M, Fernández-Cabada T, Bourguignon N, Karp P, Peñaherrera AB, Helguera G, Lerner B, Pérez MS, Mertelsmann R.

PLoS One. 2018 Mar 1;13(3):e0193605. doi: 10.1371/journal.pone.0193605. eCollection 2018.

3.

Favourable outcomes of poor prognosis diffuse large B-cell lymphoma patients treated with dose-dense Rituximab, high-dose Methotrexate and six cycles of CHOP-14 compared to first-line autologous transplantation.

Strüßmann T, Fritsch K, Baumgarten A, Fietz T, Engelhardt M, Mertelsmann R, Ihorst G, Duyster J, Finke J, Marks R.

Br J Haematol. 2017 Sep;178(6):927-935. doi: 10.1111/bjh.14802. Epub 2017 Jun 23.

PMID:
28643323
4.

Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage.

Schwab L, Goroncy L, Palaniyandi S, Gautam S, Triantafyllopoulou A, Mocsai A, Reichardt W, Karlsson FJ, Radhakrishnan SV, Hanke K, Schmitt-Graeff A, Freudenberg M, von Loewenich FD, Wolf P, Leonhardt F, Baxan N, Pfeifer D, Schmah O, Schönle A, Martin SF, Mertelsmann R, Duyster J, Finke J, Prinz M, Henneke P, Häcker H, Hildebrandt GC, Häcker G, Zeiser R.

Nat Med. 2014 Jun;20(6):648-54. doi: 10.1038/nm.3517. Epub 2014 May 18.

PMID:
24836575
5.

CLL B-cell receptors can recognize themselves: alternative epitopes and structural clues for autostimulatory mechanisms in CLL.

Binder M, Müller F, Frick M, Wehr C, Simon F, Leistler B, Veelken H, Mertelsmann R, Trepel M.

Blood. 2013 Jan 3;121(1):239-41. doi: 10.1182/blood-2012-09-454439. No abstract available.

6.

NT-pro-BNP: not the prognostic all-rounder in elderly patients undergoing allogeneic stem cell transplantation.

Haas PS, Ihorst G, Schnitzler S, Wäsch R, Marks R, Bertz H, Mertelsmann R, Finke J, Deschler B.

Ann Hematol. 2012 Dec;91(12):1929-35. doi: 10.1007/s00277-012-1529-8. Epub 2012 Jul 31.

PMID:
22847152
7.

Anti-tumor activity of a B-cell receptor-targeted peptide in a novel disseminated lymphoma xenograft model.

Wehr C, Müller F, Schüler J, Tomann T, Nitschke C, Seismann H, Spillner E, Klingner K, Schneider-Merck T, Binder M, Fiebig HH, Mertelsmann R, Trepel M.

Int J Cancer. 2012 Jul 15;131(2):E10-20. doi: 10.1002/ijc.26464. Epub 2011 Nov 19.

8.

B-cell receptor epitope recognition correlates with the clinical course of chronic lymphocytic leukemia.

Binder M, Müller F, Jackst A, Léchenne B, Pantic M, Bacher U, Zu Eulenburg C, Veelken H, Mertelsmann R, Pasqualini R, Arap W, Trepel M.

Cancer. 2011 May 1;117(9):1891-900. doi: 10.1002/cncr.25755. Epub 2010 Nov 29.

9.

The microenvironment differentially impairs passive and active immunotherapy in chronic lymphocytic leukaemia - CXCR4 antagonists as potential adjuvants for monoclonal antibodies.

Buchner M, Brantner P, Stickel N, Prinz G, Burger M, Bär C, Dierks C, Pfeifer D, Ott A, Mertelsmann R, Gribben JG, Veelken H, Zirlik K.

Br J Haematol. 2010 Oct;151(2):167-78. doi: 10.1111/j.1365-2141.2010.08316.x. Epub 2010 Aug 25.

PMID:
20738306
10.

XXIII International Association for Comparative Research on Leukemia and Related Diseases Symposium: from molecular pathogenesis to targeted therapy in leukemia and solid tumors.

Hackanson B, Becker H, Berg T, Binder M, Dierks C, Duque-Afonso J, Lairmore MD, Schäfer HS, Schnitzler M, Zeiser R, Martens U, Mertelsmann R, Lübbert M.

Cancer Res. 2008 Jul 15;68(14):5512-8. doi: 10.1158/0008-5472.CAN-07-6859. No abstract available.

11.

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).

Pfreundschuh M, Schubert J, Ziepert M, Schmits R, Mohren M, Lengfelder E, Reiser M, Nickenig C, Clemens M, Peter N, Bokemeyer C, Eimermacher H, Ho A, Hoffmann M, Mertelsmann R, Trümper L, Balleisen L, Liersch R, Metzner B, Hartmann F, Glass B, Poeschel V, Schmitz N, Ruebe C, Feller AC, Loeffler M; German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

Lancet Oncol. 2008 Feb;9(2):105-16. doi: 10.1016/S1470-2045(08)70002-0. Epub 2008 Jan 15.

PMID:
18226581
12.

Essential role of stromally induced hedgehog signaling in B-cell malignancies.

Dierks C, Grbic J, Zirlik K, Beigi R, Englund NP, Guo GR, Veelken H, Engelhardt M, Mertelsmann R, Kelleher JF, Schultz P, Warmuth M.

Nat Med. 2007 Aug;13(8):944-51. Epub 2007 Jul 15.

PMID:
17632527
13.

Identification of their epitope reveals the structural basis for the mechanism of action of the immunosuppressive antibodies basiliximab and daclizumab.

Binder M, Vögtle FN, Michelfelder S, Müller F, Illerhaus G, Sundararajan S, Mertelsmann R, Trepel M.

Cancer Res. 2007 Apr 15;67(8):3518-23.

14.

Treatment decision-making for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: problems and approaches.

Deschler B, de Witte T, Mertelsmann R, Lübbert M.

Haematologica. 2006 Nov;91(11):1513-22. Review.

15.

160 years of multiple myeloma: progress and challenges.

Engelhardt M, Mertelsmann R.

Eur J Cancer. 2006 Jul;42(11):1507-9. No abstract available.

PMID:
16880116
16.

The epitope recognized by rituximab.

Binder M, Otto F, Mertelsmann R, Veelken H, Trepel M.

Blood. 2006 Sep 15;108(6):1975-8. Epub 2006 May 16.

17.

Imatinib mesylate as a novel treatment option for hypereosinophilic syndrome: two case reports and a comprehensive review of the literature.

Müller AM, Martens UM, Hofmann SC, Bruckner-Tuderman L, Mertelsmann R, Lübbert M.

Ann Hematol. 2006 Jan;85(1):1-16. Epub 2005 Sep 1.

PMID:
16136348
18.

Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology.

Müller AM, Ihorst G, Mertelsmann R, Engelhardt M.

Ann Hematol. 2005 Jan;84(1):1-12. Epub 2004 Oct 9. Review.

PMID:
15480663
19.

Hematopoietic stem cell transplantation: more than just hematopoietic?

Spyridonidis A, Mertelsmann R, Finke J.

J Cancer Res Clin Oncol. 2004 Mar;130(3):127-34. Epub 2004 Jan 16. Review.

PMID:
14727105
20.

Meeting summary: European Workshop on Stem Cells, European Centre for the Validation of Biomedical Testing Methods, Institute for Health and Consumer Protection, Joint Research Centre, Ispra, Italy, November 21-23, 2001.

Gribaldo L, Alison M, Andrews PW, Bremer S, Donovan PJ, Knaän-Shanzer S, Mertelsmann R, Spielmann H, Testa NG, Triffitt JT, Zipori D, de Wynter E.

Exp Hematol. 2002 Jul;30(7):628-33. No abstract available.

PMID:
12135658

Supplemental Content

Loading ...
Support Center